Abstract
ABSTRACT
Recently, a complete genome sequence of Mycoplasma bovirhinis HAZ141_2 was published showing the presence of a 54-kB prophage-like region. Bioinformatic analysis revealed that this region has a more than 40% GC content and a chimeric organization with three structural elements—a prophage continuous region, a restriction-modification cassette, and a highly transmittable aadE-sat4-aphA-3 gene cluster found in both Gram-positive and Gram-negative bacteria. It is known that aadE confers resistance to streptomycin, sat4 governs resistance to streptothricin/nourseothricin, and aphA-3 is responsible for resistance to kanamycin and structurally related antibiotics. An aadE-like (aadE*) gene of strain HAZ141_2 encodes a 228-amino acid (aa) polypeptide whose carboxy-terminal domain (positions 44 to 206) is almost identical to that of a functional 302-aa AadE (positions 140 to 302). Transcription analysis of the aadE*-sat4-aphA-3 genes showed their cotranscription in M. bovirhinis HAZ141_2. Moreover, a common promoter for aadE*-sat4-aphA-3 was mapped upstream of aadE* using 5′ rapid amplification of cDNA ends analysis. Determination of MICs to aminoglycosides and nourseothricin revealed that M. bovirhinis HAZ141_2 is highly resistant to kanamycin and neomycin (≥512 μg/ml). However, MICs to streptomycin (64 μg/ml) and nourseothricin (16 to 32 μg/ml) were similar to those identified in the prophageless M. bovirhinis type strain PG43 and Israeli field isolate 316981. We cloned the aadE*-sat4-aphA-3 genes into a low-copy-number vector and transferred them into antibiotic-sensitive Escherichia coli cells. While the obtained E. coli transformants were highly resistant to kanamycin, neomycin, and nourseothricin (MICs, ≥256 μg/ml), there were no changes in MICs to streptomycin, suggesting a functional defect of the aadE*.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference70 articles.
1. 1. Yao J, Moellering R. 2007. Antibacterial agents, p 1077–1113. In Murray P, Baron E, Jorgensen J, Landry M, Pfaller M (ed), Manual of clinical microbiology. ASM Press, Washington, DC.
2. In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria;Ho;J Antimicrob Chemother,1997
3. 3. Bryskier A. 2005. Antibiotics and antibacterial agents: classifications and structure—activity relationships, p 13–38. In Bryskier A (ed), Antimicrobial agents. ASM Press, Washington, DC.
4. 4. Puglisi JD, Blanchard SC, Dahlquist KD, Eason RG, Fourmy D, Lynch SR, Recht MI, Yoshizawa S. 2000. Aminoglycoside antibiotics and decoding, p 419–430. In Garrett RA, Douthwaite SR, Liljas A, Matheson AT, Moore PB, Noller HF (ed), The ribosome: structure, functions, antibiotics, and cellular interactions. ASM Press, Washington, DC.
5. Interaction of antibiotics with functional sites in 16S ribosomal RNA;Moazed;Nature,1987
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献